FASN and ovarian cancer: Increased AMPK levels were found to inhibit ACC expression and activity, resulting in a decrease in fatty acid synthesis with no change in FASN protein expression, eventually causing cytotoxicity in SKOV3 human ovarian cancer cells after C93 treatment.